Page results
-
UCLH has achieved excellent results in the 2024 National Adult Inpatient Survey, with patients rating their overall care 8.4 out of 10. This gives UCLH the second highest score of London’s acute teaching hospitals.
-
On 11 August, UCLH went live with digital pathology, joining Royal Free London and Whittington Health in a coordinated North Central London (NCL) rollout. This is a significant milestone in our journey to modernise diagnostic services, moving from traditional glass slides to digital images, and a key ambition of the 10 Year Health Plan for England to shift “from analogue to digital.”
-
This page is for people who may need a RIG and their carers.
-
This information explains what you can expect from your care at the AL Amyloidosis Treatment Centre.
-
A new report from NHS England’s Behavioural Science Unit (BSU) looks at the key reasons behind delays in treating painful sickle cell crises, and outlined practical solutions to improve…
-
This page is for patients having planned neurosurgery.
-
This page explains what the homecare delivery service service is and how to access it for patients with Multiple Sclerosis.
-
The world’s largest-ever clinical trial of treatments to slow or stop the progression of Parkinson’s disease has launched at UCLH,
-
UCLH and Whittington Health have a long history of working together to benefit patients and staff. A small, but growing, number of staff work at both UCLH and Whittington Health…
-
A multiple sclerosis (MS) patient in the UK is the first to receive CAR T cell therapy in a UCLH clinical trial testing whether this personalised treatment may slow or even halt the progression of the disease.
File results
-
-
-
-
FOI2017123 Information on the price paid, total expenditure and total volume held of Cyanide antidotes, Levothyroxine and Primidone medications
-
FOI/2021/0438 - Dermatology service costs and contract values
-
FOI/2021/0556 - Artworks purchased and held and their value (2018 - 2021)
-
FOI/2022/0217 - Medications for dermatological conditions
-
FOI/2022/0221 - Asthma medications
-
FOI/2022/0275 - Biologic medications within dermatology
-
FOI/2022/0576 - Medications within dermatology